EU Regulators Take A Practical Approach To Addressing Nitrosamine Contamination

Medic staff at work in the laboratory. Background
Chemical and biological drug sponsors must review their products for possible presence of nitrosamines • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance